Quantitative imaging of 124I with PET/CT in pretherapy lesion dosimetry: Effects impairing image quantification and their corrections

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 55, Issue 1, 2011, Pages 21-43

  Jentzen, W ^a   Freudenberg, L ^a   Bockisch, A ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Dosimetry; Image quantification; Iodine 124; Positron emission tomography; Radionuclide therapy

Indexed keywords

3 (IODOBENZYL)GUANIDINE I 124; FLUORINE 18; IODINE 123; IODINE 124; IODINE 131; SODIUM IODIDE I 124; SODIUM IODIDE I 131; UNCLASSIFIED DRUG;

ACCURACY; ARTIFACT; CANCER PATIENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; GAMMA RADIATION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MEASUREMENT; PHANTOM; PHOTON; QUANTITATIVE ANALYSIS; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; REVIEW; THYROID CANCER;

ARTIFACTS; ELECTRONS; GAMMA RAYS; HUMANS; IODINE RADIOISOTOPES; MODELS, BIOLOGICAL; NEOPLASMS; PHANTOMS, IMAGING; PHOTONS; POSITRON-EMISSION TOMOGRAPHY; RADIOBIOLOGY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79957511354     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Stabin MG, Brill AB. State of the art in nuclear medicine dose assessment. Semin Nucl Med 2008;38:308-20. (Pubitemid 352033563)
2. Stabin MG. The case for patient-specific dosimetry in radionuclide therapy. Cancer Biother Radiopharm 2008;23:273-84. (Pubitemid 351931455)
3. Thierens HM, Monsieurs MA, Bacher K. Patient dosimetry in radionuclide therapy: the whys and the wherefores. Nucl Med Commun 2005;26:593-9. (Pubitemid 40910863)
4. Chu SYF, Ekström LP and Firestone RB 1999 The Lund/LBNL nuclear data search. Database version 2.0 [Internet]. [cited 2011 January 28]. Availabe at: http://nucleardata.nuclear.lu.se/nucleardata/toi/.
5. 131I imaging in targeted radiotherapy. Cancer Biother Radiopharm 2005;20:77-84.
6. Rault E, Vandenberghe S, Van Holen R, De Beenhouwer J, Staelens S, Lemahieu I. Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131). Cancer Biother Radiopharm 2007;22:423-30.
7. Van Holen R, Staelens S, Vandenberghe S. SPECT imaging of high energy isotopes and isotopes with high energy contaminants with rotating slat collimators. Med Phys 2009;36:4257-67.
8. Koral KF, Huberty JP, Frame B, Matthay KK, Maris JM, Regan D et al. Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma. Eur J Nucl Med Mol Imaging 2008;35:2105-12.
9. Filesi M, Colandrea M, Montesano T, D'Apollo R, Ronga G. Thyroid stunning in clinical practice: is it a real problem? Minerva Endocrinol 2009;34:29-36.
10. Ott RJ. Imaging technologies for radionuclide dosimetry. Phys Med Biol 1996;41:1885-94. (Pubitemid 26333628)
11. Flux G, Bardies M, Monsieurs M, Savolainen S, Strand SE, Lassmann M. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy. Z Med Phys 2006;16:47-9.
12. Alavi A, Basu S. Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time? Eur J Nucl Med Mol Imaging 2008;35:1554-9.
13. Mawlawi O, Kappadath SC, Pan T, Rohren E, Macapinlac HAA. Factors affecting quantification in PET/CT imaging. Current Medical Imaging Reviews 2008;4:34-45. (Pubitemid 351234609)
14. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009;50:11S-20S.
15. Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010;37:181-200.
16. Vriens D, Visser EP, de Geus-Oei LF, Oyen WJ. Methodological considerations in quantification of oncological FDG PET studies. Eur J Nucl Med Mol Imaging 2010;37:1408-25.
17. Livingood JJ, Seaborg GT. Radioactive isotopes of iodine. Phys Rev 1938;54:775-82.
18. Phillips AF. The choice of a radioactive isotope for treatment of carcinoma of the thyroid. Brit J Radiol 1957;30:247-53.
19. Matthews CM, Tucker BA. Theoretical comparison of iodine-124 and iodine-131 thyroid dosimetry. Phys Med Biol 1961;5:245-53.
20. Phillips AF, Haybittle JL, Newbery GR. Use of iodine-124 for the treatment of carcinoma of the thyroid. Acta Unio Int Contra Cancrum 1960;16:1434-8.
21. Goolden AW, Fowler JF, Matthews CM. Comparison of iodine 124 and iodine 131 for thyroid ablation. Br J Radiol 1963;36:346-9.
22. Grudzinski JJ, Yoriyaz H, Deluca PM Jr, Weichert JP. Patient specific treatment planning for systemically administered radiopharmaceuticals using PET/CT and Monte Carlo simulation. Appl Radiat Isot 2010;68:59-65.
23. 124I. Eur J Nucl Med 1985;10:472-6.
24. Ott J, Bateman JE, V Batty V, Clack R, Fielding S, Flower MA et al. Measurement of thyroid volume and uptake using positron emission tomography. Br J Radiol 1985;58:824.
25. Ott RJ, Batty V, Webb BS, Flower MA, Leach MO, Clack R et al. Measurement of radiation dose to the thyroid using positron emission tomography. Br J Radiol 1987;60:245-51. (Pubitemid 17029102)
26. Lambrecht RM, Woodhouse N, Phillips R, Wolczak D, Qureshi A, Reyes ED et al. Investigational study of iodine-124 with a positron camera. Am J Physiol Imaging 1988;3:197-200. (Pubitemid 19047802)
27. Flower MA, Schlesinger T, Hinton PJ, Adam I, Masoomi AM, Elbelli MA et al. Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol 1989;15:345-57.
28. Flower MA, Irvine AT, Ott RJ, Kabir F, McCready VR, Harmer CL et al. Thyroid imaging using positron emission tomography - a comparison with ultrasound imaging and conventional scintigraphy in thyrotoxicosis. Br J Radiol 1990;63:325-30. (Pubitemid 20158023)
29. O'Connell ME, Flower MA, Hinton PJ, Harmer CL, McCready VR. Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol 1993;28:16-26.
30. Flower MA, al-Saadi A, Harmer CL, McCready VR, Ott RJ. Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy. Eur J Nucl Med 1994;21:531-6. (Pubitemid 24189417)
31. Pentlow KS, Graham MC, Lambrecht RM, Cheung NK, Larson SM. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med Phys 1991;18:357-66.
32. 124Iodine in patients with breast cancer. Int J Cancer 1991;47:344-7.
33. Larson SM, Pentlow KS, Volkow ND, Wolf AP, Finn RD, Lambrecht RM et al. PET scanning of iodine-124-3F9 as an approach to tumour dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med 1992;33:2020-3.
34. 124I-mIBG positron emission tomography. Br J Radiol 1992;65:787-91.
35. Jentzen W, Schmitz J, Binse I, Bockisch A, Poeppel T. Patienten-spezifische Iod-124-MIBG Dosimetrie zur Abschätzung der Ganzkörper- und Läsionsdosen bei der Iod-131-MIBG Therapie von Neuroblastomen und malignen Phäochromozytomen. 49. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Bregenz, 13.-16. April 2011. Nuklearmedizin: V37 [In press].
36. Poeppel T, Schmitz J, Binse I, Bockisch A, Jentzen W. Jod-124-MIBG-Dosimetrie von Neuroendokrinen Tumouren (NET) vor möglicher Jod-131-MIBG-Therapie. 49. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Bregenz, 13.-16. April 2011. Nuklearmedizin: V38 [In press].
37. Erdi YF., Macapinlac H, Larson SM, Erdi AK, Yeung H, Furhang EE et al. Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Positron Imaging 1999;2:41-6.
38. Eschmann SM, Reischl G, Bilger K, Kupferschläger J, Thelen MH, Dohmen BM et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med Mol Imaging 2002;29:760-7.
39. Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A et al. Patient-specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 2004;45:1366-7.
40. Jentzen W. Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging. Phys Med Biol 2010;55:2365-98.
41. Qaim SM. Radiochemical determination of nuclear data for theory and applications. J Radioanal Nucl Chem 2010;284:489-505.
42. Martin CC, Christian BT, Satter MR, Nickerson LH, Nickles RJ. Quantitative PET with positron emitters that emit prompt gamma rays. IEEE Trans Med Imaging 1995;14:681-7.
43. 124I. Appl Radiat Isot 2002;56:673-9. (Pubitemid 34252911)
44. Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B et al. Quantitative imaging of iodine-124 with PET. J Nucl Med 1996;37:1557-02.
45. 124I. Phys Med Biol 2004;49:5505-28.
46. 124I PET for applications in diagnostic and pharmacokinetic drug studies. J Nucl Med 2005;46:113P.
47. 86Y. Nucl Med Commun 2006;27:237-45. (Pubitemid 44391811)
48. Herzog H, Tellmann L, Scholten B, Coenen HH, Qaim SM. PET imaging problems with the non-standard positron emitters yttrium-86 and iodine-124. Q J Nucl Med Mol Imaging 2008;52:159-65. (Pubitemid 351721936)
49. Jentzen W, Weise R, Kupferschläger J, Freudenberg L, Brandau W, Bares R et al. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems. Eur J Nucl Med Mol Imaging 2008;35:611-23. (Pubitemid 351661669)
50. 124I imaging on a Philips Gemini dual GS PET/CT system. Eur J Nucl Med Mol Imaging 2009;36:1037-48.
51. Surti S, Scheuermann R, Karp JS. Correction technique for cascade gammas in 1-124 imaging on a fully-3D, time-of-flight PET Scanner. IEEE Trans Nucl Sci 2009;56:653-60.
52. Evans RD. The Atomic Nucleus. New York, NY: McGraw-Hill; 1972. p. 628.
53. Pentlow KS, Finn RD, Larson SM, Erdi YE, Beattie BJ, Humm JL. Quantitative imaging of yttrium-86 with PET: the occurrence and correction of anomalous apparent activity in high density regions. Clin Positron Imaging 2000;3:85-90.
54. Barker WC, Szajek LP, Green SL, Carson RE. Improved quantification for Tc-94m PET imaging. IEEE Trans Nucl Sci 2001;48:739-42. (Pubitemid 32945683)
55. 76Br with 2D and 3D PET. Phys Med Biol 2002;47:3519-34. (Pubitemid 35214680)
56. Beattie BJ, Finn RD, Rowland DJ, Pentlow KS. Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays. Med Phys 2003;30:2410-23. (Pubitemid 37129747)
57. Kohlmyer SG, Miyaoka RS, Shoner SC, Lewellen TK, Eary JF. Quantitative accuracy of PET imaging with yttrium-86. J Nucl Med 1999;40:P280.
58. Buchholz HG, Herzog H, Förster GJ, Reber H, Nickel O, Rösch F et al. PET imaging with yttrium-86.- comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction. Eur J Nucl Med Mol Imaging 2003;30:716-20. (Pubitemid 36612954)
59. + in 2D mode Cancer. Biother Radiopharm 2004;19:482-90. (Pubitemid 39281339)
60. 82Rb PET. J Nucl Med 2008;49:P64.
61. Walrand S, Jamar F, Mathieu I, De Camps J, Lonneux M, Sibomana M et al. Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86. Euro J Nucl Med Mol Imaging 2003;30:354-61. (Pubitemid 36692859)
62. 131I. J Nucl Med 2006;47:1375-81. (Pubitemid 47544894)
63. Lodge M, Messina S, Geyser-Stoops S, Schweizer B, von Busch H, Line B. Calibration of a 3D PET scanner for iodine-124. J Nucl Med 2006;47:364P.
64. Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci 2000;47:1587-94.
65. Accorsi R, Adam LE, Werner ME, Karp JS. Optimization of a fully 3D single scatter simulation algorithm for 3D PET. Phys Med Biol 2004;49:2577-98. (Pubitemid 38967946)
66. 124I PET imaging. Eur J Nucl Med Mol Imaging 2009;36:OP066.
67. Beattie BJ, Pentlow KS. A correction for cascade coincidences in 3D utilizing the delayed coincidence sinogram. J Nucl Med 2004;45:411P.
68. Karp JS, Muehllehner G, MankofF DA, Ordonez CE, Ollinger JM, Daube-Witherspoon ME et al. Continuous-slice PENN-PET: a positron tomograph with volume imaging capability. J Nucl Med 1990;31:617-27. (Pubitemid 20179702)
69. Daghighian F, Pentlow KS, Larson SM, Graham MC, DiResta GR, Yeh SD et al. Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma. Eur J Nucl Med 1993;20:402-9. (Pubitemid 23204615)
70. 124I PET dosimetry in advance differentiated cancer. Nuklearmedizin 2007;46:121-8.
71. Jentzen W, Freudenberg L, Eising EG, Sonnenschein W, Knust J, Bockisch A. Optimized iodine-124 dosimetry protocol of radioiodine therapy of differentiated thyroid Cancer. J Nucl Med 2008;49:1017-23. (Pubitemid 351793444)
72. 124I PET/CT in patients with differentiated thyroid cancer. Q J Nucl Med Mol Imaging 2009;53:536-45.
73. 124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison. J Nucl Med 2009;50:844-7.
74. 124I PET/CT dosimetric comparisons. Eur J Nucl Med Mol Imaging 2010;37:2267-76.
75. Rousset O, Rahmim A, Alavi A, Zaidi H. Partial volume correction strategies in PET. PET Clin 2007;2:235-49.
76. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumour imaging. J Nucl Med 2007;48:932-45. (Pubitemid 46909922)
77. Zaidi H, El Naqa I. PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques. Eur J Nucl Med Mol Imaging 2010;37:2165-87.
78. Jentzen W, Freudenberg L, Eising EG, Heinze M, Brandau W, Bockisch A. Segmentation of PET volumes by iterative image thresholding. J Nucl Med 2007;48:108-14. (Pubitemid 47555383)
79. Geworski L, Knoop BO, Levi de Cabrejas M, Knapp WH, Munz DL. Recovery correction for quantification in emission tomography: a feasibility study. Eur J Nucl Med 2000;27:161-9. (Pubitemid 30102021)
80. Furhang EE, Larson SM, Buranapong P, Humm JL. Thyroid cancer dosimetry using clearance fitting. J Nucl Med 1999;40:131-6. (Pubitemid 29044183)
81. Stabin MG, Konijnenberg MW. Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes. J Nucl Med 2000;41:149-60. (Pubitemid 30046697)
82. 125I in and around water spheres simulating micrometastases of differentiated thyroid cancer. Radiat Res 2001;156:419-29.
83. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission tomography: 1. Effect of object size. J Comput Assist Tomogr 1979;3:299-308.
84. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE. Quantitation in positron emission computed tomography: 5. Physical-anatomical effects. J Comput Assist Tomogr 1981;5:734-43.
85. Kessler RM, Ellis JT, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984;8:514-22. (Pubitemid 14122897)
86. Zito F, Gilardi MC, Magnani P, Fazio F. Single-photon emission tomographic quantification in spherical objects: effects of object size and background. Eur J Nucl Med 1996;23:263-71.
87. Dewaraja YK, Ljungberg M, Koral KF. Monte Carlo evaluation of object shape effects in iodine-131 SPET tumour activity quantification. Eur J Nucl Med 2001;28:900-6. (Pubitemid 32662553)
88. Turkington T, Degrado T, Sampson W Small spheres for lesion detection phantoms. IEEE Nuclear Science Symp Conf Record (IEEE); 2001. p. 2234-7.
89. Bazañez-Borgert M, Bundschuh RA, Herz M, Martinez MJ, Schwaiger M. Radioactive spheres without inactive wall for lesion simulation in PET. Z Med Phys 2008;18:37-42 (Pubitemid 351337644)
90. Huang SC, Hoffman EJ, Phelps ME, Kuhl DE. Quantitation in positron emission computed tomography: 3. Effect of sampling. J Comput Assist Tomogr 1980;4:819-26. (Pubitemid 11247416)
91. Bendriem B, Dewey SL, Schlyer DJ, Wolf AP, Volkow ND. Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning. IEEE Trans Med Imaging 1991;10:216-22. (Pubitemid 21645546)
92. Miller TR, Wallis JW, Grothe RA. Design and use of PET tomographs: the effect of slice spacing. J Nucl Med 1990;31:1732-9. (Pubitemid 20347061)
93. Pevsner A, Nehmeh SA, Humm JL, Mageras GS, Erdi YE. Effect of motion on tracer activity determination in CT attenuation corrected PET images: a lung phantom study. Med Phys 2005;32:2358-62. (Pubitemid 41023196)
94. McCall KC, Barbee DL, Kissick MW, Jeraj R. PET imaging for the quantification of biologically heterogeneous tumours: measuring the effect of relative position on image-based quantification of dose-painting targets. Phys Med Biol 2010;55:2789-806.
95. Hoffman EJ, Huang SC, Plummer D, Phelps ME. Quantitation in positron emission computed tomography: 6. Effect of nonuniform resolution. J Comput Assist Tomogr 1982;6:987-99.
96. Jentzen W, Hobbs RF, Stahl A, Knust J, Sgouros G, Bockisch A. Pre-therapeutic iodine-124 PET(/CT) dosimetry confirms low average absorbed doses per administered iodine-131 activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2010;37:884-95.
97. Ruhlmann M, Bockisch A, Jentzen W. Prätherapeutische Blutdosimetrie bei der Radiojodtherapie des differenzierten Schilddrüsenkarzinoms: Ist eine genaue Blutdosimetrie allein auf der Grundlage der Ganzkörper-Messung möglich? 49. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Bregenz, 13.-16. April 2011.
98. Pentlow KS, Mawlawi O, Daghighian F, Finn RD, Humm JL, Larson SM. Imaging of tracer amounts of I-124 in the presence of therapeutic amounts of I-131 with a standard PET scanner. J Nucl Med 1998;39:51P.
99. 124I PET/CT. J Nucl Med 2009;50:909-11.